Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Perdana Bangun Pusaka Tbk (KONI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Perdana Bangun Pusaka TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Perdana Bangun Pusaka Tbk dan Brigit Biofarmaka Teknologi Tbk.: Perdana Bangun Pusaka Tbk diperdagangkan di Rp2.070 (kapitalisasi pasar 661,44 M, volume 24 jam 30,6 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Perdana Bangun Pusaka Tbk jauh lebih besar — sekitar 4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (324 rb vs 30,6 rb). Mana yang lebih baik tergantung tujuan investasimu.

KONIOBAT
Kapitalisasi Pasar
661,44 M166,01 M
Volume
30,6 rb324 rb
Lot
3063,24 rb
Perputaran
66,04 jt77,68 jt
Harga Rata-rata
2.158,17239,75
Nilai Transaksi
66,04 jt77,68 jt
Harga Ekuilibrium Indikatif
240
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

KONI
Lihat detail
OBAT
Lihat detail

Tentang Perdana Bangun Pusaka Tbk

PT. Perdana Bangun Persaka Tbk conducting business in the field of photography trade business and its equipment, and capital participation in its affiliates. The company is established in 1987 and registered at the Jakarta Stock Exchange since 1995 and a sole distributor of photography products produced by Konica Corporation, Japan. Product marketed by the company are as follows: KONICA color film and photography paper, KONICA photo printing machine, KONIKA X-ray film and chemicals for photography of KONICA trade mark.

Selengkapnya di halaman KONI

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT